CASI
NASDAQ · Biotechnology
Casi Pharmaceuticals Inc
$0.92
-0.03 (-2.66%)
Open$0.92
Previous Close$0.95
Day High$0.95
Day Low$0.91
52W High$34.87
52W Low$20.14
Volume—
Avg Volume68.9K
Market Cap14.33M
P/E Ratio27.39
EPS$1.17
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+4,239.8% upside
Current
$0.92
$0.92
Target
$40.13
$40.13
$29.11
$40.13 avg
$50.28
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.76M | 9.51M | 9.21M |
| Net Income | 476.4K | 434.3K | 561.3K |
| Profit Margin | 4.9% | 4.6% | 6.1% |
| EBITDA | 702.0K | 716.5K | 618.7K |
| Free Cash Flow | 456.1K | 350.1K | 392.2K |
| Rev Growth | +1.2% | +3.9% | +7.8% |
| Debt/Equity | 0.31 | 0.38 | 0.38 |
Dividend
Dividend Yield2.82%
Annual Dividend$0.91
Payout Ratio77.5%
Frequencyquarterly
Ex-DividendApr 24, 2026
Pay DateMay 10, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |